Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is one of the highest fatality rate cancers with poor survival rates. The tumor microenvironment (TME) is vital for tumor immune responses, leading to resistance to chemotherapy and poor prognosis of PDAC patients. This study aimed to provide a compre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weijia, Yan, Liang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Wu, Jianhui, Tian, Xiuyun, Hao, Chunyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945593/
https://www.ncbi.nlm.nih.gov/pubmed/33718118
http://dx.doi.org/10.3389/fonc.2020.618215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945593/
https://www.ncbi.nlm.nih.gov/pubmed/33718118
http://dx.doi.org/10.3389/fonc.2020.618215

Ejemplares similares